Helen Albert on Muck Rack

Helen Albert

Verified
Berlin, Germany
As seen in: Inside Precision Medicine, Forbes, Nature, New Scientist, Taylor & Francis Online, Chemical & Engineering News (C&EN), Forbes Brasil, Forbes Japan, Genetic Engineering & Biotechnology News, Chemistry World, Labiotech and
Covers:  Life sciences, technology, medicine, health, general science, biotech/pharma, innovation
Freelance journalist. Focus: med, life sci, bioanth & biotech. Bylines: Forbes, BMJ, New Scientist, Chemistry World, Labiotech & more. Senior ed. @Inside_PM

Get in touch with Helen

Contact Helen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Helen Albert’s Biography

Read Full Bio →

Helen is a freelance science and health journalist based in Berlin. She has written for a range of publications including Forbes New Scientist and the BMJ. Prior to going freelance in 2020, she was Editor-in-Chief at Labiotech.eu, an English-language, digital publication based in Berlin focusing on the European biotech industry. Before moving to Germany, she worked at a range of different science and health-focused publications in London. She was Editor of The Biochemist magazine and blog, but …

Articles

Imaging Technique Can Differentiate Lung Inflammation from Fibrosis

|
By Helen Albert 
| Inside Precision Medicine
Credit: SEBASTIAN KAULITZKI/SCIENCE PHOTO LIBRARY/Getty Images A type of computed tomography (CT) imaging known as SPECT (Single Photon Emission Computed Tomography) in combination with a new imaging agent could allow clinicians and researchers to visualize inflammation in the lungs to better target treatment to patients. Interstitial lung disease includes over 200 conditions that scar and inflame the lungs.
Open in Who Shared Issue with article?

Precancerous Adenomas Alter Gut Microbiome for Long Period

|
By Helen Albert 
| Inside Precision Medicine
Credit: Raycat/Getty Images Research shows people who have precancerous polyps removed have an altered gut microbiome for around 12 years after undergoing surgery, which may explain why there is a significant risk of progressing to colorectal cancer in these individuals despite the surgery. “Early detection and resection of adenomas through colonoscopy are critical strategies for preventing colorectal cancer.
Open in Who Shared Issue with article?

Cell Therapy Shows Promise for Treating Advanced Liver Disease

|
By Helen Albert 
| Inside Precision Medicine
Credit: Kateryna Kon/Science Photo Library A type of cell therapy made up of macrophage cells can lower risk for death or need for a liver transplant in people with cirrhosis due to advanced liver disease. The research, published in Cell Stem Cell, was a long term follow-up study of patients recruited into an earlier Phase I/II trial and showed a 27.5% drop in risk for death or liver transplant in those who received the therapy versus usual care over up to four years of follow up.
Open in Who Shared Issue with article?
See all 1,308 licensed articles (1,359 Total)

Interview

What was your first job as a journalist?

working as a writer at medwireNews in London

How do you prefer to be pitched on stories?

By email

What's your favorite social network?

Twitter or LinkedIn

Actions

Share this page

Get in touch with Helen

Contact Helen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified